Targeted therapies are relatively new in anti-cancer treatment and target the specific proteins or enzymes that play a role in the cancer cells' growth. They work by attacking cancer cells without damaging healthy cells.
The treatments currently available include Herceptin (also known as trastuzumab) and Tykerb (also known as lapatinib) .
Herceptin
Herceptin does not work for everyone, only for those whose breast cancers are HER2 positive (thought to be around 15-20% of all women diagnosed with breast cancer). It is used in conjunction with chemotherapy and although expensive, it is funded through the government's Pharmaceutical Benefits Scheme (PBS).
Are there any side effects?
Herceptin can cause heart problems in some women, which can be detected with heart tests before symptoms occur. Your medical oncologist will discuss any possible benefits and drawbacks of taking Herceptin as part of your treatment.
More information
- Read about BCNA's early breast cancer Herceptin campaign.
- Join our online network if you think talking to others online and sharing experiences will help.
- The Guide for women with early breast cancer, available in My Journey Kit, has comprehensive information on Herceptin.
- The Medicare website has more information about the PBS and Herceptin.
